Åsberg received institutional research grants and lecture fees to her institution from AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, and Institut Produits Synthése. Sandset and de ...
The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...
Abdulla also aims to further strengthen relationships with regional governments and key healthcare stakeholders to ensure sustainable patient access to Boehringer Ingelheim’s portfolio of leading ...
Spending the day facing the challenges of kidney patients helps workers at a CT pharmaceutical company understand disease and ...
Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...
Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...
The financial terms indicate future success-based milestone payments and royalties on sales, aligning with Surrozen's existing partnership with Boehringer Ingelheim. The collaboration is based on ...
Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...
Boehringer Ingelheim; Opsens; Philips; Insight Lifetech; Biotronik; Sanofi Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the ...
Boehringer Ingelheim; Daiichi-Sankyo/Elil Lilly and Company; GSK; Lumira DX; Novartis; Roche Diagnostics; Thermo Fisher Receive the the latest news, research, and presentations from major meetings ...
Indigo Ag has hired a new chief financial officer, while a biotech developing a potential epilepsy drug got a Series A as ...